Green Finance and Human Health Outcomes: The Role of Public Renewable Energy Investment in China, India and Selected Economies
グリーンファイナンスと人間の健康アウトカム:中国、インドおよびその他経済における公的再生可能エネルギー投資の役割 (AI 翻訳)
Dechun Wang, Hao Ding
🤖 gxceed AI 要約
日本語
本研究は、2000~2023年の5つの新興経済国を対象に、公的再生可能エネルギー投資(グリーンファイナンス)が健康アウトカムに与える影響を検証。平均寿命との頑健な関連は見られず、5歳未満死亡率への効果は弱く、COVID-19期間で変化。CO₂媒介経路も支持されず、グリーンファイナンスだけでは健康効果は限定的で、補完的な投資が必要と結論。
English
This study examines whether public renewable-energy finance (green finance) improves health outcomes in five emerging economies using panel data from 2000-2023. It finds no robust association with life expectancy, and the under-5 mortality link is weak and regime-dependent. The CO₂ mediation channel is not supported, suggesting health co-benefits require complementary investments, not just green finance.
Unofficial AI-generated summary based on the public title and abstract. Not an official translation.
📝 gxceed 編集解説 — Why this matters
日本のGX文脈において
日本では、グリーンファイナンスの健康便益に関する議論はまだ限定的だが、本論文は公的投資の環境・健康への複合的効果を評価する視点を提供する。ただし、日本固有の政策文脈への直接的な示唆は少ない。
In the global GX context
The paper offers a rare empirical test of the health co-benefits of climate finance in emerging economies, contributing to the global debate on green finance's non-climate outcomes. It cautions that energy-transition finance alone does not automatically improve health, which is relevant for integrated policy design under frameworks like ISSB.
👥 読者別の含意
🔬研究者:Useful for scholars studying the intersection of climate finance and public health, especially the conditional nature of co-benefits.
🏢実務担当者:Limited direct applicability; sustainability teams should note that green finance may not directly improve health metrics without complementary health investments.
🏛政策担当者:Relevant for policymakers designing green finance programs; highlights need for cross-sectoral coordination.
📄 Abstract(原文)
Climate-aligned finance is increasingly expected to yield measurable health co-benefits, yet it remains unclear whether public renewable-energy investment translates into better population health in major emerging economies, particularly after COVID-19. This study examines whether climate-focused public renewable-energy finance (green finance) improves human health outcomes, whether environmental quality acts as a transmission channel, and whether the COVID-19 period altered the strength or direction of these relationships. We compile a balanced annual macro-panel for Brazil, China, India, Indonesia, and Mexico over 2000–2023, drawing on harmonised international sources for public renewable-energy finance, health outcomes, emissions, and macro-structural controls. Baseline models are estimated using country fixed effects with Driscoll–Kraay standard errors, complemented by panel-corrected standard errors and Feasible Generalised Least Squares (FGLS) for robustness. A two-equation mediation framework tests environmental quality proxied by CO₂ emissions, with indirect effects evaluated using non-parametric bootstrap inference (1,000 replications). Structural change is assessed via sub-sample estimates for 2000–2019 and 2020–2023, alongside country-specific heterogeneity checks. The results show no robust contemporaneous association between green finance and life expectancy, while the association with under-5 mortality is estimator- and regime-dependent, appearing protective pre-COVID but attenuating during 2020–2023. The CO2-based mediation pathway is not statistically supported, consistent with a weak first-stage link between green finance and emissions. Overall, the findings refine theory on finance–environment–health linkages and inform practice by indicating that health co-benefits from energy-transition finance are conditional on complementary structural and health-system investments, which is very important from the perspective of sustainable development.
🔗 Provenance — このレコードを発見したソース
- semanticscholar https://ph.pollub.pl/index.php/preko/article/download/8839/5440first seen 2026-07-04 05:36:41
🔔 こうした論文の新着を逃したくない方は キーワードアラート に登録(無料・3キーワードまで)。
gxceed は公開メタデータに基づく研究支援データセットです。要約・翻訳・解説は AI 支援で生成されています。 最終的な解釈・検証は利用者が原典資料に基づいて行うことを前提とします。